Another mechanism of platelet activation by cancer cells is mediated by ADAM9 (a disintegrin and metalloproteinase 9), which is found in several cancer types and has been correlated with tumor aggressiveness and poor prognosis. This evidence concerns the gene ADAM9 and cancer.